BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Busatto S, Iannotta D, Walker SA, Di Marzio L, Wolfram J. A Simple and Quick Method for Loading Proteins in Extracellular Vesicles. Pharmaceuticals (Basel) 2021;14:356. [PMID: 33924377 DOI: 10.3390/ph14040356] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Bruno MC, Cristiano MC, Celia C, d'Avanzo N, Mancuso A, Paolino D, Wolfram J, Fresta M. Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis. ACS Nano 2022;16:19665-90. [PMID: 36512378 DOI: 10.1021/acsnano.2c06393] [Reference Citation Analysis]
2 Yan B, Liang Y. New Therapeutics for Extracellular Vesicles: Delivering CRISPR for Cancer Treatment. Int J Mol Sci 2022;23. [PMID: 36555398 DOI: 10.3390/ijms232415758] [Reference Citation Analysis]
3 Walker SA, Davidovich I, Yang Y, Lai A, Goncalves JP, Deliwala V, Busatto S, Shapiro S, Koifman N, Salomon C, Talmon Y, Wolfram J. Sucrose-based cryoprotective storage of extracellular vesicles. Extracellular Vesicle 2022;1:100016. [DOI: 10.1016/j.vesic.2022.100016] [Reference Citation Analysis]
4 McCann J, Sosa-Miranda CD, Guo H, Reshke R, Savard A, Zardini Buzatto A, Taylor JA, Li L, Gibbings DJ. Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNA. J Extracell Vesicles 2022;11:e12220. [PMID: 36214496 DOI: 10.1002/jev2.12220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Stavrou A, Ortiz A. Extracellular Vesicles: A Novel Tool in Nanomedicine and Cancer Treatment. Cancers 2022;14:4450. [DOI: 10.3390/cancers14184450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Alptekin A, Parvin M, Chowdhury HI, Rashid MH, Arbab AS. Engineered exosomes for studies in tumor immunology. Immunol Rev 2022. [PMID: 35808839 DOI: 10.1111/imr.13107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang M, Walker SA, Aguilar Díaz de León JS, Davidovich I, Broad K, Talmon Y, Borges CR, Wolfram J. Extracellular vesicle glucose transporter-1 and glycan features in monocyte-endothelial inflammatory interactions. Nanomedicine 2022;42:102515. [PMID: 35074500 DOI: 10.1016/j.nano.2022.102515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Matsuzaka Y, Yashiro R. Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications. Membranes 2022;12:550. [DOI: 10.3390/membranes12060550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Busatto S, Yang Y, Iannotta D, Davidovich I, Talmon Y, Wolfram J. Considerations for extracellular vesicle and lipoprotein interactions in cell culture assays. J Extracell Vesicles 2022;11:e12202. [PMID: 35362268 DOI: 10.1002/jev2.12202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 Shen J, Ma M, Shafiq M, Yu H, Lan Z, Chen H. Microfluidics-Assisted Engineering of pH/Enzyme Dual-Activatable ZIF@Polymer Nanosystem for Co-Delivery of Proteins and Chemotherapeutics with Enhanced Deep-Tumor Penetration. Angew Chem Int Ed Engl 2022;61:e202113703. [PMID: 34989079 DOI: 10.1002/anie.202113703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Filipović L, Kojadinović M, Popović M. Exosomes and exosome-mimetics as targeted drug carriers: Where we stand and what the future holds? Journal of Drug Delivery Science and Technology 2022;68:103057. [DOI: 10.1016/j.jddst.2021.103057] [Reference Citation Analysis]
12 Wang X, Pham A, Kang L, Walker SA, Davidovich I, Iannotta D, TerKonda SP, Shapiro S, Talmon Y, Pham S, Wolfram J. Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines. Pharmaceutics 2021;14:16. [PMID: 35056912 DOI: 10.3390/pharmaceutics14010016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Piffoux M, Volatron J, Cherukula K, Aubertin K, Wilhelm C, Silva AKA, Gazeau F. Engineering and loading therapeutic extracellular vesicles for clinical translation: A data reporting frame for comparability. Adv Drug Deliv Rev 2021;178:113972. [PMID: 34509573 DOI: 10.1016/j.addr.2021.113972] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
14 Moloudizargari M, Asghari MH, Goel A. The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers. Biochem Pharmacol 2021;192:114714. [PMID: 34332957 DOI: 10.1016/j.bcp.2021.114714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]